Daylin Gamiotea Turro of the Verma Lab receives AHA award

Daylin Gamiotea Turro, a postdoctoral fellow in the Verma lab, has received the 2024 Research Supplement to Promote Diversity in Science Award from the American Heart Association (AHA). With the support of this fellowship, Daylin will contribute to our ongoing research on the Encephalomyosynangiosis (EMS) procedure to improve post-stroke recovery. EMS promotes a vascular niche that may ultimately improve blood flow in ischemic tissue and potentially speed up recovery after a stroke. In her AHA project, she will specifically focus on how immune cells react when we implant temporalis muscle on the brain cortex after a stroke.

Daylin Gamiotea Turro/Verma


This entry was posted in Awards.